PURE— PURE BIOSCIENCE, INC.

$8M mkt cap

Metric	FY2025	FY2024	FY2023	FY2022
Total revenue	$2.2M+12.2%	$2.0M+4.6%	$1.9M+1.3%	$1.9M
Cost of goods sold	$899K+10.9%	$811K-10.5%	$906K+6.2%	$853K
Gross Profit	$1.3M+13.1%	$1.2M+18.6%	$971K-2.9%	$1.0M
Selling, general and administrative	$3.3M-18.1%	$4.0M-7.5%	$4.3M+6.2%	$4.1M
Research and development	$316K+4.6%	$302K+1.7%	$297K-6.9%	$319K
Impairment of fixed assets	$60K	—	$315K+472.7%	$55K
Total operating costs and expenses	$3.6M-17.7%	$4.3M-11.6%	$4.9M+4.0%	$4.7M
Loss from operations	-$2.3M+28.8%	-$3.2M+19.1%	-$3.9M-5.9%	-$3.7M
Interest expense, net	-$299K-92.9%	-$155K-1007.1%	-$14K-133.3%	-$6K
Other income (expense), net	$172K+4400.0%	-$4K+0.0%	-$4K	—
Total other income (expense)	-$127K+20.1%	-$159K-783.3%	-$18K-107.7%	$233K
Net loss	-$2.4M+28.4%	-$3.4M+15.4%	-$4.0M-13.5%	-$3.5M
Basic net loss per share	-$0.02+33.3%	-$0.03+25.0%	-$0.04+0.0%	-$0.04
Diluted net loss per share	-$0.02+33.3%	-$0.03+25.0%	-$0.04+0.0%	-$0.04
Shares used in computing basic net loss per share	$111862884.00+0.0%	$111856473.00+0.4%	$111404418.00+25.4%	$88835424.00
Shares used in computing diluted net loss per share	$111862884.00+0.0%	$111856473.00+0.4%	$111404418.00+25.4%	$88835424.00
Product [Member]
Royalty [Member]

Source: SEC EDGAR XBRL. % change vs prior period shown where available.

Pro feature

Unlock 11 more years of annual history and full quarterly detail on Pro.

Source: SEC EDGAR 10-K and 10-Q filings. Last 4 years annual and quarterly free, full history (up to 20 years) on Pro.